Axsome Therapeutics正接近转变药品阵容。
令人兴奋的成长股票备受追捧,但由于种种原因,有些股票却不受关注。这就给精明的投资者提供了机会,在股价大幅上涨之前抢占先机。
中等市值生物科技公司Madrigal Pharmaceuticals...查看全文
产业链观察03-25 19:20
#药闻简讯# $Axsome Therapeutics(AXSM)$ 宣布AXS-12在发作性睡病SYMPHONY3期试验中达到主要终点,与安慰剂相比,AXS-12在统计学上显著减少了猝倒发作(p=0.018)查看全文
医药魔方03-27 16:41
3月25日,Axsome宣布AXS-12(瑞波西汀)治疗发作性睡病的III期SYMPHONY研究达到了主要终点,即AXS-12可以显著降低发作性睡病患者的猝倒频率。
SYMPHONY研究是一项随机、双盲、多中心、安慰剂对照临床试验(n=90),评估了AXS-12(5mg,第1周每日1次,第2-5周每日2次)在发作性睡病患者中的疗效...查看全文
起步龙耀路03-26 16:06
$Axsome Therapeutics(AXSM)$ 最近美股生科也不好赚,q4业绩不错,发作性睡病成功,结果还是跌了不少。 可能还是预期差比较大的大癌种能成才会刺激股价。查看全文
Axsome Therapeutics(AXSM)03-25 21:15
$Axsome Therapeutics(AXSM)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0000950170-24-035656 Act: 34 Size: 224 KB 网页链接查看全文
Axsome Therapeutics(AXSM)03-25 21:05
$Axsome Therapeutics(AXSM)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0000950170-24-035655 Act: 34 Size: 11 MB 网页链接查看全文
Axsome Therapeutics(AXSM)02-20 20:15
$Axsome Therapeutics(AXSM)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-016797 Act: 34 Size: 433 KB 网页链接查看全文
Axsome Therapeutics(AXSM)02-21 05:35
$Axsome Therapeutics(AXSM)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0000950170-24-017174 Act: 34 Size: 18 MB 网页链接查看全文
Axsome Therapeutics(AXSM)02-14 06:05
$Axsome Therapeutics(AXSM)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-020385 Act: 34 Size: 13 KB 网页链接查看全文
$Axsome Therapeutics(AXSM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-039617 Size: 8 KB 网页链接
$Axsome Therapeutics(AXSM)$ 144 Report of proposed sale of securities Accession Number: 0001921094-24-000504 Act: 33 Size: 4 KB 网页链接
$Axsome Therapeutics(AXSM)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0000950170-24-038894 Act: 34 Size: 207 KB 网页链接
$Axsome Therapeutics(AXSM)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0000950170-24-035656 Act: 34 Size: 224 KB 网页链接
$Axsome Therapeutics(AXSM)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0000950170-24-035655 Act: 34 Size: 11 MB 网页链接
$Axsome Therapeutics(AXSM)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0000950170-24-033148 Act: 34 Size: 207 KB 网页链接
$Axsome Therapeutics(AXSM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-032432 Size: 19 KB 网页链接
$Axsome Therapeutics(AXSM)$ 144 Report of proposed sale of securities Accession Number: 0001921094-24-000410 Act: 33 Size: 4 KB 网页链接
$Axsome Therapeutics(AXSM)$ 144 Report of proposed sale of securities Accession Number: 0001921094-24-000384 Act: 33 Size: 4 KB 网页链接
$Axsome Therapeutics(AXSM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-023375 Size: 5 KB 网页链接